Paper · 29081663
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 55
Download this page as JSON| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,059,987 | Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer. | J Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/27059987 | PubMed |
| 2 | 21,918,895 | Dual biological effects of the cytokines interleukin-10 and interferon-γ. | Cancer Immunol Immunother | 2011 | https://conductscience.org/library/papers/21918895 | PubMed |
| 3 | 26,562,534 | High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma. | PLoS One | 2015 | https://conductscience.org/library/papers/26562534 | PubMed |
| 4 | 27,342,842 | NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells. | J Immunol | 2016 | https://conductscience.org/library/papers/27342842 | PubMed |
| 5 | 23,359,812 | Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. | PLoS One | 2013 | https://conductscience.org/library/papers/23359812 | PubMed |
| 6 | 17,555,582 | Practical methods for incorporating summary time-to-event data into meta-analysis. | Trials | 2007 | https://conductscience.org/library/papers/17555582 | PubMed |
| 7 | 24,378,899 | Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer. | Oncol Rep | 2014 | https://conductscience.org/library/papers/24378899 | PubMed |
| 8 | 27,932,443 | PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. | EMBO Mol Med | 2017 | https://conductscience.org/library/papers/27932443 | PubMed |
| 9 | 26,024,796 | PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma. | Lung Cancer | 2015 | https://conductscience.org/library/papers/26024796 | PubMed |
| 10 | 24,175,978 | Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment. | Eur J Haematol | 2014 | https://conductscience.org/library/papers/24175978 | PubMed |
| 11 | 24,885,059 | Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation. | J Transl Med | 2014 | https://conductscience.org/library/papers/24885059 | PubMed |
| 12 | 26,423,423 | Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer. | Cancer Immunol Immunother | 2015 | https://conductscience.org/library/papers/26423423 | PubMed |
| 13 | 28,024,695 | Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis. | Lung Cancer | 2017 | https://conductscience.org/library/papers/28024695 | PubMed |
| 14 | 27,797,936 | IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. | Gut | 2018 | https://conductscience.org/library/papers/27797936 | PubMed |
| 15 | 28,769,571 | Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis. | Onco Targets Ther | 2017 | https://conductscience.org/library/papers/28769571 | PubMed |
| 16 | 23,986,257 | PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients. | J Neurosci | 2013 | https://conductscience.org/library/papers/23986257 | PubMed |
| 17 | 23,622,135 | The epidemiology of pancreatitis and pancreatic cancer. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23622135 | PubMed |
| 18 | 25,658,629 | Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation. | J Thorac Oncol | 2015 | https://conductscience.org/library/papers/25658629 | PubMed |
| 19 | 27,742,686 | Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. | Cancer Res | 2016 | https://conductscience.org/library/papers/27742686 | PubMed |
| 20 | 22,949,674 | Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22949674 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/29081663/references